Sign in
4

Changes in Ownership

Cabaletta Bio, Inc. Filed Acc 0000899243-19-026018

Options or other derivatives

  • Chief Financial Officer acquired 66,463 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Marda Anup Chief Financial Officer 2019-10-24 Grant or award · Stock Option (Right to Buy) +66,463 66,463 D
Loading xslF345X03/doc4.xml…